Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:BBLG NASDAQ:IVF NASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$0.41+1.0%$0.38$0.20▼$2.64$2.80M-1.431.94 million shs102,235 shsBBLGBone Biologics$1.23-1.6%$1.27$1.05▼$6.75$2.24M0.9314,510 shs16,875 shsIVFINVO Fertility$1.59-4.2%$1.95$1.38▼$183.60$2.96M2.33781,193 shs145,729 shsSSKNStrata Skin Sciences$0.15+0.6%$0.16$0.11▼$3.86$883K-0.06258,455 shs6,650 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical+3.57%-2.17%+7.15%-5.30%-75.24%BBLGBone Biologics+1.45%-3.52%-4.62%-1.64%-74.66%IVFINVO Fertility-2.35%-2.35%-12.17%-60.90%-99.12%SSKNStrata Skin Sciences+24.17%+14.62%-1.19%-35.50%-93.61%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$0.41+1.0%$0.38$0.20▼$2.64$2.80M-1.431.94 million shs102,235 shsBBLGBone Biologics$1.23-1.6%$1.27$1.05▼$6.75$2.24M0.9314,510 shs16,875 shsIVFINVO Fertility$1.59-4.2%$1.95$1.38▼$183.60$2.96M2.33781,193 shs145,729 shsSSKNStrata Skin Sciences$0.15+0.6%$0.16$0.11▼$3.86$883K-0.06258,455 shs6,650 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical+3.57%-2.17%+7.15%-5.30%-75.24%BBLGBone Biologics+1.45%-3.52%-4.62%-1.64%-74.66%IVFINVO Fertility-2.35%-2.35%-12.17%-60.90%-99.12%SSKNStrata Skin Sciences+24.17%+14.62%-1.19%-35.50%-93.61%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.00Hold$2.00387.80% UpsideBBLGBone Biologics 1.00SellN/AN/AIVFINVO Fertility 2.50Moderate Buy$20.001,157.86% UpsideSSKNStrata Skin Sciences 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest SSKN, AMIX, IVF, and BBLG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/2/2026AMIXAutonomix Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/18/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/6/2026IVFINVO Fertility Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/4/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)4/27/2026BBLGBone Biologics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)4/20/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026BBLGBone Biologics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$0.85 per shareN/ABBLGBone BiologicsN/AN/AN/AN/A$3.00 per shareN/AIVFINVO Fertility$6.84M0.42N/AN/A($3,583.22) per share0.00SSKNStrata Skin Sciences$30.98M0.03N/AN/A$1.19 per share0.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$16.72M-$3.55N/AN/AN/AN/A-239.36%-192.46%8/12/2026 (Estimated)BBLGBone Biologics-$3.11M-$2.27N/AN/AN/AN/A-50.47%-47.40%8/13/2026 (Estimated)IVFINVO Fertility-$9.10M-$3,151.46N/AN/AN/A-417.02%N/A-92.42%N/ASSKNStrata Skin Sciences-$10.09M-$1.41N/AN/AN/A-35.64%-476.73%-33.49%8/19/2026 (Estimated)Latest SSKN, AMIX, IVF, and BBLG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/2/2026Q4 2025IVFINVO FertilityN/A$472.78N/A$472.78N/A$1.60 million5/14/2026Q1 2026BBLGBone Biologics-$0.43-$0.43N/A-$0.43N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ASSKNStrata Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.454.45BBLGBone BiologicsN/A16.1116.11IVFINVO FertilityN/A0.120.10SSKNStrata Skin Sciences10.220.950.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%BBLGBone Biologics34.30%IVFINVO Fertility12.02%SSKNStrata Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical6.20%BBLGBone Biologics6.10%IVFINVO Fertility0.72%SSKNStrata Skin Sciences40.92%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical16.91 million6.48 millionN/ABBLGBone Biologics21.80 million1.69 millionNot OptionableIVFINVO Fertility101.79 million1.77 millionNo DataSSKNStrata Skin Sciences1205.89 million3.48 millionNot OptionableSSKN, AMIX, IVF, and BBLG HeadlinesRecent News About These CompaniesNew Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric VitiligoMay 18, 2026 | globenewswire.comSTRATA Skin Sciences Confirms Nasdaq DelistingFebruary 19, 2026 | globenewswire.comSSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's EfficacyFebruary 18, 2026 | zacks.comSTRATA cites study supporting 308 nm laser for psoriasisFebruary 18, 2026 | msn.comJohns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer LaserFebruary 18, 2026 | globenewswire.comSTRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque PsoriasisFebruary 17, 2026 | globenewswire.comSTRATA Skin Sciences stock plunges after Nasdaq delisting noticeFebruary 12, 2026 | in.investing.comStrata Skin Sciences to Delist and Go DarkFebruary 11, 2026 | tipranks.comLaseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin SciencesFebruary 11, 2026 | globenewswire.comStrata Skin Sciences showcases XTRAC, TheraclearX at TeraCILAD 2025December 10, 2025 | msn.comSTRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in MexicoDecember 9, 2025 | globenewswire.comStrata Skin Sciences Inc (SSKN) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...November 16, 2025 | finance.yahoo.comSTRATA Skin Sciences Reports Q3 2025 Financial ResultsNovember 14, 2025 | msn.comStrata Skin Sciences Reports Q3 2025 Revenue DeclineNovember 13, 2025 | msn.comSTRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call TranscriptNovember 13, 2025 | seekingalpha.comSTRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate UpdateNovember 13, 2025 | markets.businessinsider.comSTRATA Skin Sciences to Report Q3 Results and Host Investor Call November 13November 13, 2025 | msn.comA Peek at Strata Skin Sciences's Future EarningsNovember 13, 2025 | benzinga.comStrata Skin Sciences announces CMS recognition of expanded CPT codesNovember 6, 2025 | msn.comSTRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption ...November 6, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSSKN, AMIX, IVF, and BBLG Company DescriptionsAutonomix Medical NASDAQ:AMIX$0.41 +0.00 (+0.99%) Closing price 04:00 PM EasternExtended Trading$0.40 -0.01 (-3.41%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Bone Biologics NASDAQ:BBLG$1.23 -0.02 (-1.60%) Closing price 03:53 PM EasternExtended Trading$1.25 +0.02 (+1.22%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.INVO Fertility NASDAQ:IVF$1.59 -0.07 (-4.22%) Closing price 04:00 PM EasternExtended Trading$1.50 -0.09 (-5.35%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Strata Skin Sciences NASDAQ:SSKN$0.15 +0.00 (+0.60%) As of 11:24 AM EasternSTRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
